Future Treatment Avenues in Parkinson’s disease
Dear Colleague,
It is our great pleasure to invite you to participate in the Symposium on Future Treatment Avenues in Parkinson’s disease (and Related Disorders), to be held in Bordeaux between May 4-6, 2010.
http://www.inb.u-bordeaux2.fr/siteneuro2/pages/Symposia/Parkinson/Parkinson_disease.php
The objective of this meeting is to brainstorm and dialogue between international Parkinson’s disease experts and representatives of leading healthcare companies and innovative biotech startups to better understand the evolution of the therapeutic area and its strategic implications for the Healthcare industry.
These insights will be fundamental for decisions on clinical development of existing pipeline molecules and will drive the directions of future research and development activities.
The topics cover the most striking unmet treatment needs of our patients with the ambition to provide a cure for Parkinson’s disease in the future. Each expert will give an interactive presentation where he will briefly review his topic, define meaningful surrogate markers for the design of future clinical trials and identify the most promising and innovative treatment avenues.
We hope that you will be available to join us for this exciting event looking into the future of Parkinson’s disease therapies.
Best regards,
Dr Wassilios Meissner Professor François Tison Dr Erwan Bezard